Search research articles
Contact Us
Filters
Showing results (331-340 of 579) with videos related to
Page
of 58
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2022
Primary prevention recommendations to reduce the risk of cognitive decline
Marwan N Sabbagh, Adriana Perez, Thomas M Holland, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 1, 2010
Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex
Rachel F Lane, Summer M Raines, John W Steele, et al.
The EMBO Journal
|
October 24, 2018
A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-β oligomers
Andrés Norambuena, Horst Wallrabe, Rui Cao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development
Dmitry Prokopenko, Sarah L Morgan, Kristina Mullin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 2, 2021
Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development
Dmitry Prokopenko, Sarah L Morgan, Kristina Mullin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 27, 2022
Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
Andrew B Caldwell, Qing Liu, Can Zhang, et al.
Science (New York, N.Y.)
|
May 25, 2013
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"
Karthikeyan Veeraraghavalu, Can Zhang, Sean Miller, et al.
The Journal of Biological Chemistry
|
March 28, 1998
Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain
R D Moir, T Lynch, A I Bush, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 20, 2025
HDAC11 displays neuropathological alterations and offers as a novel drug target for Alzheimer's disease
Ping Bai, Prasenjit Mondal, Yan Liu, et al.
Human Genetics
|
August 1, 1986
Studies of a DNA marker (G8) genetically linked to Huntington disease in British families
S Youngman, M Sarfarazi, O W Quarrell, et al.
Page
of 58
Search research articles
Search
Showing results (331-340 of 579) with videos related to
Sort By:
Page
of 58
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2022
Primary prevention recommendations to reduce the risk of cognitive decline
Marwan N Sabbagh, Adriana Perez, Thomas M Holland, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 1, 2010
Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex
Rachel F Lane, Summer M Raines, John W Steele, et al.
The EMBO Journal
|
October 24, 2018
A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-β oligomers
Andrés Norambuena, Horst Wallrabe, Rui Cao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development
Dmitry Prokopenko, Sarah L Morgan, Kristina Mullin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 2, 2021
Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development
Dmitry Prokopenko, Sarah L Morgan, Kristina Mullin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 27, 2022
Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
Andrew B Caldwell, Qing Liu, Can Zhang, et al.
Science (New York, N.Y.)
|
May 25, 2013
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"
Karthikeyan Veeraraghavalu, Can Zhang, Sean Miller, et al.
The Journal of Biological Chemistry
|
March 28, 1998
Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain
R D Moir, T Lynch, A I Bush, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 20, 2025
HDAC11 displays neuropathological alterations and offers as a novel drug target for Alzheimer's disease
Ping Bai, Prasenjit Mondal, Yan Liu, et al.
Human Genetics
|
August 1, 1986
Studies of a DNA marker (G8) genetically linked to Huntington disease in British families
S Youngman, M Sarfarazi, O W Quarrell, et al.
Page
of 58